IP Verse

Intranasal Epinephrine Formulations And Methods For The Treatment Of Disease

Patent No. EP3678649 (titled "Intranasal Epinephrine Formulations And Methods For The Treatment Of Disease") was filed by Aegis Therapeutics on Feb 6, 2019. The application was issued on Dec 21, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
AERAJul 24, 2023BARDEHLE PAGENBERG SL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3678649

AEGIS THERAPEUTICS
Application Number
EP19751807A
Filing Date
Feb 6, 2019
Status
Granted And Under Opposition
Sep 23, 2022
Publication Date
Dec 21, 2022
External Links
Slate, EP3678649B8, Google Patents